1. Introduction {#s1}
===============

Invasive coronary angiography is the gold standard method for the detection of coronary artery stenosis.[@b1] Recent advances including the introduction of multidetector computed tomography (MDCT), a submillimeter scan with high spatial and temporal resolution, have allowed substantial progress in the non-invasive diagnosis of coronary artery disease. Several studies about the role of 64-slice CT in the diagnosis of coronary artery disease (CAD) showed that their sensitivities and specificities were more than 90% and 96%.[@b2]--[@b5] In the latter context, MDCT images include portions of the lung, mediastinum, chest wall, spine and bones and upper abdomen,[@b6] in addition to the heart, coronary arteries and great vessels. With the ever-increasing rate of coronary CT investigations, extracardiac findings may be more frequently encountered in patients with suspected coronary artery disease.

Chest pain can be of cardiovascular or noncardiovascular origin. Because in 14% of patients with unstable angina, coronary angiography revealed no significant stenosis in the epicardial coronary artery,[@b7] confirming that diagnostic methods evaluating myocardial ischemia, or coronary obstructions, are insufficient for a complete evaluation of the chest. This study was, therefore, designed to evaluate the prevalence of extracardiac findings during the MDCT evaluation of ischemic heart disease.

2. Methods {#s2}
==========

2.1. Study patients {#s2a}
-------------------

This study included 620 consecutive patients who underwent MDCT from March 2007 to March 2008 at our institution for the evaluation of coronary artery disease. All patients were in stable condition; individuals who were admitted with acute coronary syndrome were excluded from this study.

2.2. Multidetector CT scan {#s2b}
--------------------------

Coronary CT angiography was performed with a 64-detector row MDCT scanner (Discover DVCT, GE Healthcare, USA). The CT scanning was performed with a detector collimation of 0.625 mm at 120 kV, using 650 mAs and rotation speed of 0.35 s. Slice thicknesses were 0.625 mm and the reconstruction interval was 0.625 mm. A single oral dose of 25--100 mg metoprolol (Yuhan Pharma, Inc, Korea) was administered two hours before the MDCT scan, if the heart rate was \> 60 beats/min. The contrast enhanced scan area was set from upper neck proximally to upper abdominal area distally. A scan delay time was calculated to the maximal opacification of the proximal ascending aorta after bolus injection of contrast medium. A total of 40--60 mL of low-osmolar, non-ionic contrast medium (Bono-rex™ 350mg I/mL; Dai Han Pharm, Seoul, Korea) was injected via the antecubital vein at a rate of 4 mL/s.

2.3. CT image analysis {#s2c}
----------------------

All image processing and analysies were performed on a GE Advantage Windows Workstation (GE Healthcare, USA). A comprehensive image analysis, including cardiac structures, bone, lung and soft tissues, was performed by a radiologist. Significant coronary artery stenosis was defined as \> 50% of arterial diameter stenosis on a maximal intensity projection image. Extracardiac findings were regarded as abnormal when these studies required additional imaging, invasive study or a further follow-up by an experienced radiology doctor who had read more than 1000 cases of MDCT. Patients were classified into two groups, namely those with extracardiac findings (Group A) and without extracardiac findings (Group B). Clinical data were obtained from the medical records and compared the two groups.

2.4. Statistical analysis {#s2d}
-------------------------

All numerical variables were expressed as mean ± SD. Categorical variables were expressed as frequencies. The Student\'s *t*-test or non-parametric analysis with the Mann-Whitney *U* test was used to analyze continuous variables for comparisons between groups. The Chi-square test or the Fisher\'s exact test was used for comparisons of categorical variables expressed as frequencies. Multivariate logistic regression analysis was used to evaluate predictors for the presence of extracardiac findings. SPSS version 17.0 (SPSS Inc., Chicago, Illinois) was used for data analysis. A value of *P* \< 0.05 was considered statistically significant.

3. Results {#s3}
==========

The 620 patients included 306 males (49.4%) with a mean age of 66.3 ± 8.7 years. Of these patients, 24.7% were current smokers, and hypertension was the most frequent risk factor for atherosclerotic ischemic heart disease (32.6%). Significant coronary artery stenosis was found in 41.6% of patients, and a total number of 468 lesions was found in those patients ([Table 1](#jgc-10-03-242-t01){ref-type="table"}).

###### Baseline characteristics of the study population.

  Variables                           Value (*n* = 620)
  ---------------------------------- -------------------
  Male gender                            306 (49.4%)
  Age (yrs)                              66.3 ± 8.7
  Smoking                                153 (24.7%)
  Diabetes mellitus                      117 (18.9%)
  Hypertension                           202 (32.6%)
  Cerebrovascular accident                44 (7.1%)
  Body mass index \> 25%                 125 (20.2%)
  LDL cholesterol level, mg/dL          115.3 ± 38.8
  hsCRP level, mg/dL                     1.7 ± 11.8
  Coronary lesion location           
   Left anterior descending artery       198 (42.3%)
   Left circumflex artery                121 (25.9%)
   Right coronary artery                 126 (26.9%)
   Left main trunk                        23 (4.9%)

Data are presented as *n* (%) or mean ± SD. LDL-C: Low density lipoprotein cholesterol; hsCRP: high sensitivity C-reactive protein.

There were some differences in clinical characteristics between Group A and Group B. [Table 2](#jgc-10-03-242-t02){ref-type="table"} shows the results of univariate analysis of the differences of clinical features and characteristics of chest discomfort between the two groups. Mean age was higher, chest pain duration was shorter and less typical, dyspnea complaint frequency was higher, and significant coronary artery stenosis was less common in Group A than in Group B. Multivariate analysis including, age, symptom duration, presence of typical chest pain and dyspnea, showed that there were no significant predictors for the presence of extracardiac findings ([Table 3](#jgc-10-03-242-t03){ref-type="table"}).

A total of 158 extracardiac findings were observed in 110 (17.7%) of the 620 patients ([Table 4](#jgc-10-03-242-t04){ref-type="table"}). Lung (36.7%), hepatobiliary system (21.5%), thyroid (19.6%) and kidney (10.8%) were common extracardiac organs with abnormal findings. Among lung abnormalities, follow-up studies were recommended for 31 pulmonary nodules measuring \< 15 mm. Four patients with lung nodules ≥15 mm underwent lung biopsy to rule out malignancy. Lung cancer, which was treated by pulmonary lobectomy, was confirmed in only one of these patients; the other three patients refused further invasive evaluation and were advised to undergo a follow-up CT evaluation. Other abnormal lung findings included pleural effusion (7.0%), pneumonia (6.3%) and pulmonary thromboembolism (1.3%). Liver and biliary tract was the second most common organ system with extracardiac findings (21.5%). Gallbladder stones were the most frequent findings, although their relation to the patient\'s clinical symptoms was unclear and none required surgical intervention. Thyroid nodule was the third most common abnormality. Of 31 thyroid nodules detected, only one patient had papillary thyroid cancer and underwent total thyroidectomy. Kidney and adrenal gland diseases were found in 19 patients. Unexplained hydronephrosis was detected in one patient, but he refused follow-up investigation. One year later, he was found to have pancreatic cancer with ureteral metastasis.

###### Differences in clinical characteristics between groups.

  Variable                                            Group A         Group B      *P*-Value
  ------------------------------------------------ -------------- --------------- -----------
  Male                                               60 (54.1%)     246 (48.3%)      0.274
  Age, yrs                                           67.9 ± 9.1     66.0 ± 8.6       0.042
  Smoking                                            24 (33.3%)     129 (38.2%)      0.441
  Diabetes mellitus                                  17 (23.6%)     100 (28.4%)      0.407
  Hypertension                                       35 (47.9%)     167 (47.3%)      0.921
  Cerebrovascular accident                            5 (6.9%)      39 (11.0%)       0.298
  Body mass index \> 25%                             26 (39.4%)     99 (32.5%)       0.280
  LDL cholesterol level, mg/dL                      114.7 ± 34.6   115.41 ± 39.7     0.892
  hsCRP level, mg/dL                                 1.9 ± 5.4      1.7 ± 12.8       0.883
  Symptoms                                                                        
   Chest pain duration, day                         19.7 ± 49.9    46.5 ± 143.9      0.011
   Typical chest pain                                23 (31.5%)     152 (45.2%)      0.032
   Atypical chest pain                               32 (43.8%)     139 (41.2%)      0.684
   Dyspnea                                           35 (47.9%)     114 (33.4%)      0.019
  Absence of significantcoronary artery stenosis     72 (64.9%)     290 (57.0%)      0.049

LDL-C: Low density lipoprotein cholesterol; hsCRP: high sensitivity C-reactive protein.

###### Multivariate logistic analysis for predictors for the presence of extracardiac findings.

  Variant                                               RR (confident interval)   *P*-value
  ---------------------------------------------------- ------------------------- -----------
  Age (*vs*. \> 80 yrs)                                                          
   50--59                                                1.396 (0.431--4.517)       0.578
   60--69                                                1.499 (0.508--4.423)       0.463
   70--79                                                1.504 (0.511--4.428)       0.458
  Symptom duration (*vs*. \> 56 days)                                            
   0--14                                                 1.420 (0.574--3.508)       0.448
   15--28                                                0.425 (0.047--3.820)       0.445
   29--56                                                1.257 (0.433--3.648)       0.674
  Typical chest pain (*vs*. Non-typical chest pain )     0.567 (0.304--1.057)       0.074
  Dyspnea (*vs*. no dyspnea )                            1.530 (0.848--2.763)       0.158

###### Prevalence of extracardiac findings by organ.

  Findings by organ                  Number of lesions   Number of follow-up investigations
  --------------------------------- ------------------- ------------------------------------
  Lung                                  58 (36.7%)                       33
   Pulmonary nodule (\< 15 mm)          31 (19.6%)                       17
   Pulmonary mass (≥ 15 mm)              4 (2.5%)                        3
   Pleural effusion                      11 (7.0%)                       7
   Pneumonia                             10 (6.3%)                       5
   Pulmonary thromboembolism             2 (1.3%)                        1
  Hepatobiliary system & Pancreas       34 (21.5%)                       14
   Gallbladder stone                    21 (13.3%)                       7
   Biliary stone                         3 (2.0%)                        1
   Liver cyst                            4 (2.5%)                        2
   Liver mass                            4 (2.5%)                        2
   Pancreatic cyst                       2 (1.3%)                        2
  Kidney                                17 (10.8%)                       8
   Renal cyst                            12 (7.6%)                       5
   Renal mass                            2 (1.3%)                        2
   Renal stone                           2 (1.3%)                        1
   Hydronephrosis                        1 (0.6%)                        0
  Adrenal gland mass                     2 (1.3%)                        0
  Thyroid nodule                        31 (19.6%)                       14
  Spinal fracture                        11 (9.7%)                       4
  Others                                 5 (3.1%)                        3
   Breast mass                           1 (0.6%)                        0
   Abdominal aortic aneurysm             1 (0.6%)                        1
   Hiatal hernia                         2 (1.3%)                        2
   Ascites                               1 (0.6%)                        0
  Total                                 158 (100%)                   76 (48.1%)

[Figure 1](#jgc-10-03-242-g001){ref-type="fig"} shows different extracardiac findings by MDCT.

![Images of extracardiac findings by multidector computed tomography.\
(A): Pulmonary nodule (biopsy -- adenocarcinoma); (B): Thyroid nodule (biopsy -- papillary carcinoma); and (C): Hydronephrosis (pancreatic cancer with ureteral metastasis).](jgc-10-03-242-g001){#jgc-10-03-242-g001}

4. Discussion {#s4}
=============

Multidetector coronary computed tomographic angiography is now being carried out with increasing frequency as a non-invasive method for the evaluation of ischemic heart disease. Because the field of view in MDCT examinations includes the lungs, bony thoracic cage, spine and upper abdomen, it is a means for detection of potential abnormalities in them. This study investigated the potential value of MDCT to detect extracardiac findings in patients complaining of chest pain, or dyspnea. We determined that 110 (17.7%) of the 620 patients who underwent MDCT had extracardiac lesions requiring further evaluation. Although the prevalence of extracardiac findings in this study is toward the low end of the range of previous studies,[@b8]--[@b11] it is very important that the reporting cardiologist or radiologist be aware of the presence and potential significance of extracardiac findings to chest pain syndromes.

The frequency of the extracardiac findings differs among studies for a variety of reasons. Several previous studies involved electron-beam CT (EBCT) examinations. Horton, *et al*.[@b8] reviewed 1,326 consecutive patients who underwent EBCT, and found that 7.8% of patients had significant extracardiac pathology requiring additional investigation: non-calcified lung nodules in 4.9%, infiltrates in 1.8%, liver lesion in 0.5% and bone abnormalities in 0.15%. The frequency of these extracardiac findings was lower than in our study because they excluded minor findings, such as granulomas, liver cysts, pleural lesions, and rib fractures. In contrast, Hunold, *et al*.[@b9] in a study of 1,812 consecutive patients undergoing EBCT, found that 53% of patients had extracardiac findings: in the lungs in 28% of patients, mediastinum in 4%, spine in 5% and abdomen in 2%. They included minor insignificant findings, such as scars, granulomas, atelectasis, degenerative arthritis and rib fractures.

Some recently published studies examined the frequency of significant extracardiac findings on MDCT examination. In the study by Gil, *et al*.[@b10] a total 258 consecutive asymptomatic participants underwent 16-slice MDCT scanning and found. One hundred and forty five patients (56.2%) to have significant extracardiac findings: lung abnormalities were detected in 91 (35.3%) patients, pericardium in 10 (3.8%), liver in 12 (4.6%), adrenal gland in 8 (3.1%) and bone in 3 (1.1%). Greenberg-Wolff, *et al*.[@b11] reviewed 134 patients who underwent 40-slice MDCT coronary angiography examinations. Extracardiac findings were observed in 76.8% of patients. Clinically significant findings were present in 39%. The most common findings were pulmonary nodules \> 4 mm (13%) and enlarged mediastinal lymph nodes \> 10 mm (10%); other significant findings included aortic aneurysm in 4.5%, spine in 9%, abdomen in 3%. Our study shows a lower prevalence of extracardiac findings than other MDCT studies, which is probably secondary to several causes. First, the field of the extracardiac region covered differs among studies. Second, patients included in the study have different clinical characteristics and symptoms. Third, the definition of "abnormal findings" is different among studies.

Some researchers have pointed out that over-reading MDCT for extracardiac findings can have untoward consequences, including additional costs and anxiety to the patients without proven benefit.[@b12] Also, a recent document of the American College of Cardiology Foundation/American Heart Association (ACC/AHA) defining the examination for evaluation and interpretation of MDCT findings, was limited to the interpretation of cardiac findings, while other reports underscore that significant extracardiac findings need further evaluation and treatment, and that ignoring, or not reporting, extracardiac findings has legal and moral implications. The American College of Radiology practice guidelines stress that professionals performing MDCT should be competent in the evaluation of cardiac, as well as non-cardiac findings.[@b13]

In conclusion, this study of elderly patients with common risk factors for malignancy, especially lung cancers, and undergoing MDCT evaluation of chest pain syndrome, confirmed that the presence of extracardiac findings is frequent and should be of concern.
